BioSig Technologies, Inc. STEX Change In Fair Value Of Exchangeable Shares Derivative Liability
Change In Fair Value Of Exchangeable Shares Derivative Liability at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:ChangeInFairValueOfExchangeableSharesDerivativeLiability.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s change in fair value of exchangeable shares derivative liability.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s change in fair value of exchangeable shares derivative liability?
- BioSig Technologies, Inc. (STEX) reported change in fair value of exchangeable shares derivative liability of $97.42M in Q4 2025.
- What does change in fair value of exchangeable shares derivative liability mean?
- Reflects the non-cash gain or loss resulting from the periodic revaluation of derivative liabilities associated with exchangeable shares. As market conditions or the company's stock price fluctuate, the fair value of these financial instruments must be adjusted, impacting reported net income without affecting immediate cash liquidity. Investors monitor this to isolate operational performance from volatility driven by complex capital structure instruments.